EU Reviewing Pfizer-BioNTech COVID-19 Vaccine In Real Time

The European health regulator has started a real-time review of the COVID-19 vaccine being developed by Pfizer and BioNTech, days after launching a similar assessment process for AstraZeneca’s vaccine.

The European Medicines Agency (EMA) said on Tuesday its human medicines committee was evaluating the first batch of non-clinical data on the vaccine from laboratory studies, and will continue to do so until enough data is available for a final decision. (https://bit.ly/34mAHiI)

The “rolling review” of the vaccine, called BNT162b2, was based on early-stage studies, which suggested that the vaccine triggered immune response, the watchdog said, as it moves ahead with its plan to speed up the approval process for COVID-19 vaccine candidates.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Covid-19 and the business of crowds

Nov 22nd 2020This month Britain’s National Exhibition Centre (NEC), the country’s largest events venue,...

Why You Should Skip Black Friday And Shop Small...

Female business owner dressing dress form in window of...

Lowe’s raises forecast as tight housing market, older homes...

A customer pushes a shopping cart towards the entrance of a Lowe's store in...

Exclusive: World Bank Seeks Board Approval For $12 Billion...

WASHINGTON: World Bank President David Malpass said on Tuesday he is seeking board approval...